Carta
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose
Fecha
2014-09-01Registro en:
Bone Marrow Transplantation. London: Nature Publishing Group, v. 49, n. 9, p. 1239-1240, 2014.
0268-3369
10.1038/bmt.2014.121
WOS:000341786700020
Autor
Santos, K. B. dos
Costa, L. J.
Atalla, A.
Pereira, J. [UNIFESP]
Hallack-Neto, A. E.